Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
Titel:
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
Auteur:
Long, Georgina V Trefzer, Uwe Davies, Michael A Kefford, Richard F Ascierto, Paolo A Chapman, Paul B Puzanov, Igor Hauschild, Axel Robert, Caroline Algazi, Alain Mortier, Laurent Tawbi, Hussein Wilhelm, Tabea Zimmer, Lisa Switzky, Julie Swann, Suzanne Martin, Anne-Marie Guckert, Mary Goodman, Vicki Streit, Michael Kirkwood, John M Schadendorf, Dirk